Moscow Multiple Sclerosis Center, Russia
Ekaterina V. Popova finished a medical faculty of Moscow Medical Academy of I.M. Sechenov in 2003. In 2005 she finished the residency of nervous diseases (Department of Postgraduate Medical Education Moscow Medical Academy of I.M. Sechenov). Since 2009 is Ph.D. (thesis: "Clinical and psychosocial factors that determine the quality of life in patients with remitting form of multiple sclerosis, preserving the functional activity"). Since 2009 is a member of the Moscow Multiple Sclerosis Center. Has authored over 25 publications on multiple sclerosis.
Disease modifying therapies (DMT) for multiple sclerosis (MS) are still very expensive. Accordingly, the implementation biosimilars into general practice, which would match the efficiency and safety of original drugs is relevant. The Moscow MS Center (MMSC) has a longitudinal experience for about 10 years of the original beta-interferon-1b (Betaferon). Since 2010 began to appear